Donaldson Company, Inc. (DCI) produces and sells filtration systems and replacement parts worldwide. The company recently announced the acquisition of Isolere Bio, Inc., an early-stage biotechnology company that produces filtration processes used to purify and manufacture pharmaceuticals.
Wall Street analysts are bullish on the stock. The consensus revenue and EPS estimates of $3.45 billion and $3.05 for the current year (ending July 2023) indicate 4.3% and 13.8% year-over-year increases, respectively. Moreover, the 12-month median price target of $68 indicates a 6.9% potential upside.
